<DOC>
	<DOCNO>NCT00635700</DOCNO>
	<brief_summary>This study aim determine whether ziprasidone superior placebo 24 week patient psychosis prodrome .</brief_summary>
	<brief_title>Ziprasidone Psychosis Prodrome</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>SIPS criterion psychosis prodrome clinically refer prolonged QTc history syncope</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>psychosis</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>prodrome</keyword>
	<keyword>ziprasidone</keyword>
	<keyword>placebo</keyword>
</DOC>